MAKO Surgical Corp. 4
4 · MAKO Surgical Corp. · Filed Dec 17, 2013
Insider Transaction Report
Form 4
Ferre Maurice R
DirectorPresident, CEO and Chairman
Transactions
- Disposition to Issuer
Employee Stock Option (right to buy)
2013-12-17$20.70/sh−194,518$4,026,523→ 0 totalExercise: $9.30Exp: 2018-02-20→ Common Stock (194,518 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2013-12-17$18.05/sh−100,000$1,805,000→ 0 totalExercise: $11.95Exp: 2020-02-04→ Common Stock (100,000 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2013-12-17$13.68/sh−150,000$2,052,000→ 0 totalExercise: $16.32Exp: 2021-02-03→ Common Stock (150,000 underlying) - Gift
Common Stock
2013-11-08−100,000→ 646,886 total - Disposition to Issuer
Employee Stock Option (right to buy)
2013-12-17$18.59/sh−200,000$3,718,000→ 0 totalExercise: $11.41Exp: 2023-02-21→ Common Stock (200,000 underlying) - Disposition to Issuer
Common Stock
2013-12-17$30.00/sh−646,886$19,406,580→ 0 total - Disposition to Issuer
Employee Stock Option (right to buy)
2013-12-17$21.94/sh−303,000$6,647,820→ 0 totalExercise: $8.06Exp: 2019-02-20→ Common Stock (303,000 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2013-12-17$16.73/sh−100,000$1,673,000→ 0 totalExercise: $13.27Exp: 2020-04-13→ Common Stock (100,000 underlying) - Disposition to Issuer
Employee Stock Option (right to buy)
2013-12-17−60,000→ 0 totalExercise: $36.43Exp: 2022-02-23→ Common Stock (60,000 underlying)
Footnotes (3)
- [F1]Includes 6,250 shares of restricted stock which became fully vested as of December 17, 2013 pursuant to the Agreement and Plan of Merger ("Merger Agreement"), dated September 25, 2013, by and among the issuer, Stryker Corporation, and Lauderdale Merger Corporation.
- [F2]Pursuant to the Merger Agreement, each share of the issuer's common stock was exchanged for a cash payment of $30.00.
- [F3]Pursuant to the Merger Agreement, each outstanding stock option, whether vested or unvested, was canceled in exchange for a cash payment equal to the amount, if any, by which $30.00 exceeded the exercise price payable per share under each such stock option.